BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for ARCHITECT HAVAb-IgM Reagents, Abbott

Product group In-vitro diagnostics
Reference 04677/09

Corrective action of Abbott for ARCHITECT HAVAb-IgM Reagents when the ARCHITECT Anti-HBs assay precedes the ARCHITECT HAVAb-IgM assay. The customers were informed about the problem and how to avoid it.

Corrective action for ARCHITECT HAVAb-IgM Reagents, Abbott , Download_VeroeffentlichtAm_EN PDF, 36KB, File does not meet accessibility standards